HPV  	HPV  	 NNP	B-NP
testing  	testing  	 NN	I-NP
in  	in  	 IN	O
prevention  	prevention  	 NN	O
of  	of  	 IN	O
cervical  	cervical  	 JJ	B-NP
cancer 	cancer 	 NN	I-NP
:  	:  	 :	O
practices  	practices  	 NNS	O
and  	and  	 CC	O
current  	current  	 JJ	O
trends  	trends  	 NNS	O
Robust  	Robust  	 JJ	B-NP
evidence  	evidence  	 NN	I-NP
supports  	supports  	 VBZ	O
new  	new  	 JJ	O
strategies  	strategies  	 NNS	O
for  	for  	 IN	O
prevention  	prevention  	 NN	O
of  	of  	 IN	O
cervical  	cervical  	 JJ	B-NP
cancer  	cancer  	 NN	I-NP
based  	based  	 VBN	O
on  	on  	 IN	O
the  	the  	 DT	O
detection  	detection  	 NN	O
of  	of  	 IN	O
persistent  	persistent  	 JJ	O
Human  	Human  	 JJ	B-NP
papillomavirus  	papillomavirus  	 NNS	I-NP
( 	( 	 -LRB-	O
HPV 	HPV 	 NNP	B-NP
)  	)  	 -RRB-	O
infection 	infection 	 NN	B-NP
,  	,  	 ,	O
the  	the  	 DT	O
causative  	causative  	 JJ	B-NP
agent  	agent  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
disease 	disease 	 NN	O
.  	.  	 .	O
New  	New  	 NNP	B-NP
HPV  	HPV  	 NNP	I-NP
infection  	infection  	 NN	I-NP
is  	is  	 VBZ	O
usually  	usually  	 RB	O
benign  	benign  	 JJ	O
and  	and  	 CC	O
transient 	transient 	 NN	O
,  	,  	 ,	O
while  	while  	 IN	O
persistent  	persistent  	 JJ	O
infection  	infection  	 NN	B-NP
with  	with  	 IN	O
one  	one  	 CD	O
of  	of  	 IN	O
-high  	-high  	 JJ	O
risk  	risk  	 NN	B-NP
HPV  	HPV  	 NNP	I-NP
explains  	explains  	 VBZ	O
almost  	almost  	 RB	O
all  	all  	 RB	O
of  	of  	 IN	O
these  	these  	 DT	O
cancers 	cancers 	 NNS	O
.  	.  	 .	O
In  	In  	 IN	O
fact 	fact 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
detection  	detection  	 NN	O
of  	of  	 IN	O
one  	one  	 CD	O
of  	of  	 IN	O
the  	the  	 DT	O
12  	12  	 CD	O
oncogenic  	oncogenic  	 CD	B-NP
HPV  	HPV  	 NNS	I-NP
increase  	increase  	 VB	O
the  	the  	 DT	O
sensitivity  	sensitivity  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
screening  	screening  	 NN	O
and  	and  	 CC	O
predicts 	predicts 	 VBZ	O
,  	,  	 ,	O
sooner  	sooner  	 RBR	O
than  	than  	 IN	O
cytology 	cytology 	 NN	B-NP
,  	,  	 ,	O
the  	the  	 DT	O
risk  	risk  	 NN	O
of  	of  	 IN	O
precancerous  	precancerous  	 JJ	B-NP
lesions 	lesions 	 NNS	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
high  	high  	 JJ	O
grade  	grade  	 NN	O
of  	of  	 IN	O
cervical  	cervical  	 FW	B-NP
intraepithelial  	intraepithelial  	 FW	I-NP
neoplasia  	neoplasia  	 FW	I-NP
( 	( 	 -LRB-	O
HG  	HG  	 NNP	B-NP
CIN 	CIN 	 NNP	I-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
Negative  	Negative  	 JJ	B-NP
HPV  	HPV  	 NNP	I-NP
detection  	detection  	 NN	I-NP
gives  	gives  	 VBZ	O
instantaneously  	instantaneously  	 VBG	O
a  	a  	 DT	O
reassurance  	reassurance  	 JJ	B-NP
close  	close  	 NN	I-NP
to  	to  	 TO	O
100 	100 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
absence  	absence  	 NN	B-NP
of  	of  	 IN	O
disease  	disease  	 NN	O
at  	at  	 IN	O
risk  	risk  	 NN	O
( 	( 	 -LRB-	O
while  	while  	 IN	O
cytology  	cytology  	 JJ	B-NP
detection  	detection  	 NN	I-NP
is  	is  	 VBZ	O
less  	less  	 JJR	O
than  	than  	 IN	O
60 	60 	 CD	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
almost  	almost  	 RB	O
guarantees  	guarantees  	 VBZ	O
protection  	protection  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
absence  	absence  	 NN	B-NP
of  	of  	 IN	I-NP
HG  	HG  	 NNP	I-NP
CIN  	CIN  	 NNP	I-NP
over  	over  	 IN	O
a  	a  	 DT	O
prolonged  	prolonged  	 JJ	O
period 	period 	 NN	O
,  	,  	 ,	O
allowing  	allowing  	 VBG	O
lengthening  	lengthening  	 NNS	O
safely  	safely  	 RB	O
the  	the  	 DT	O
screening  	screening  	 NN	B-NP
interval  	interval  	 NN	I-NP
to  	to  	 TO	O
5  	5  	 CD	O
years 	years 	 NNS	O
.  	.  	 .	O
Pooled  	Pooled  	 JJ	B-NP
HPV-based  	HPV-based  	 JJ	I-NP
screening  	screening  	 NN	I-NP
tests  	tests  	 NNS	I-NP
decrease  	decrease  	 VB	O
the  	the  	 DT	O
specificity  	specificity  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
screening  	screening  	 NN	O
and  	and  	 CC	O
increases  	increases  	 VBZ	O
the  	the  	 DT	O
number  	number  	 NN	O
of  	of  	 IN	O
colposcopy 	colposcopy 	 NN	B-NP
.  	.  	 .	O
New  	New  	 JJ	B-NP
strategies  	strategies  	 NNS	I-NP
can  	can  	 MD	O
significantly  	significantly  	 RB	O
improve  	improve  	 VB	O
the  	the  	 DT	O
specificity  	specificity  	 NN	O
of  	of  	 IN	O
HPV  	HPV  	 NNP	B-NP
screening  	screening  	 NN	I-NP
without  	without  	 IN	O
a  	a  	 DT	O
significant  	significant  	 JJ	O
impact  	impact  	 NN	O
on  	on  	 IN	O
the  	the  	 DT	O
sensitivity 	sensitivity 	 NN	O
,  	,  	 ,	O
including  	including  	 VBG	B-NP
exclusion  	exclusion  	 NN	I-NP
of  	of  	 IN	O
women  	women  	 NNS	O
less  	less  	 RBR	O
than  	than  	 IN	O
30  	30  	 CD	O
years 	years 	 NNS	O
,  	,  	 ,	O
the  	the  	 DT	O
use  	use  	 NN	O
of  	of  	 IN	O
HPV  	HPV  	 NNP	B-NP
DNA  	DNA  	 NNP	I-NP
genotyping  	genotyping  	 NN	I-NP
tests  	tests  	 NNS	I-NP
with  	with  	 IN	O
recognition  	recognition  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
most  	most  	 JJS	O
HPV  	HPV  	 NN	B-NP
at  	at  	 IN	O
risk 	risk 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
16  	16  	 CD	O
and  	and  	 CC	O
18  	18  	 CD	O
types 	types 	 NNS	O
.  	.  	 .	O
HPV  	HPV  	 NNP	B-NP
alone  	alone  	 RB	O
can  	can  	 MD	O
be  	be  	 VB	O
used  	used  	 VBN	O
as  	as  	 IN	O
a  	a  	 DT	O
screening  	screening  	 NN	B-NP
tool  	tool  	 NN	I-NP
in  	in  	 IN	O
women  	women  	 NNS	O
of  	of  	 IN	O
30  	30  	 CD	O
years  	years  	 NNS	O
+  	+  	 VBP	O
with  	with  	 IN	O
a  	a  	 DT	O
cytology  	cytology  	 JJ	B-NP
triage  	triage  	 NN	I-NP
or  	or  	 CC	O
immunocytochemical  	immunocytochemical  	 JJ	B-NP
staining  	staining  	 NN	I-NP
of  	of  	 IN	I-NP
cyto  	cyto  	 JJ	I-NP
slides  	slides  	 NNS	I-NP
for  	for  	 IN	I-NP
p16  	p16  	 CD	I-NP
of  	of  	 IN	I-NP
HPV  	HPV  	 NNP	I-NP
positive 	positive 	 JJ	I-NP
.  	.  	 .	O
Co-testing  	Co-testing  	 NNP	O
( 	( 	 -LRB-	O
cytology+  	cytology+  	 NNP	B-NP
HPV  	HPV  	 NNP	O
test 	test 	 NN	O
)  	)  	 -RRB-	O
was  	was  	 VBD	O
adopted  	adopted  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
USA  	USA  	 NNP	B-NP
as  	as  	 IN	O
a  	a  	 DT	O
standard  	standard  	 JJ	O
screening  	screening  	 NN	B-NP
option 	option 	 NN	I-NP
.  	.  	 .	O
